Trial intelligence / Profile preview

Antiplatelet therapy after transcatheter aortic valve implantation

NL-OMON25546Recruiting

Sponsor
St. Antonius Ziekenhuis
Start
Feb 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of aspirin and clopidogrel in aortic stenosis (AS) and aortic valve disease (AVD) (4 cohorts), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Co-primary endpoint. Started Feb 2014; status: recruiting.

02

Drugs

aspirinclopidogrel
03

Conditions

aortic stenosis (AS)aortic valve disease (AVD)

Beyond the preview

Go deeper on NL-OMON25546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call